Intractable myoclonic seizures in an allogeneic stem cell transplant recipient: A rare case of myoclonic epilepsy

per Robuccio, Anna, Ssentongo, Paddy, Sather, Michael D., Claxton, David F., Gilliam, Frank G.
Publicat a Epilepsy Behav Case Rep (2015)

Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model

per Liu, Qiang, Chen, Longgui, Atkinson, Jennifer M, Claxton, David F, Wang, Hong-Gang
Publicat a Cell Death Dis (2016)

Orbital Epstein-Barr Virus-Positive Polymorphic B-Cell Lymphoproliferative Disorder in an Apparently Immunocompetent Woman

per Abendroth, Michael D., Bayerl, Michael G., Wilkinson, Michael J., Claxton, David F., Specht, Charles S.
Publicat a Ocul Oncol Pathol (2017)

Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: Evidence for multiple critical loci

per Liang, Hong, Fairman, Jeff, Claxton, David F., Nowell, Peter C., Green, Eric D., Nagarajan, Lalitha
Publicat 1998

A non-coding cationic lipid DNA complex produces lasting anti-leukemic effects

per Keasey, Nikki, Herse, Zachary, Chang, Stella, Liggitt, Denny H, Lay, Marla, Fairman, Jeffery, Claxton, David F
Publicat 2010

STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemia

per Doshi, Ushma A, Shaw, Jeremy, Fox, Todd E, Claxton, David F, Loughran, Thomas P, Kester, Mark
Publicat a Signal Transduct Target Ther (2017)

Chest radiographic and CT findings in hyperleukocytic acute myeloid leukemia: A retrospective cohort study of 73 patients

per Stefanski, Michael, Jamis-Dow, Carlos, Bayerl, Michael, Desai, Ruchi J., Claxton, David F., Van de Louw, Andry
Publicat a Medicine (Baltimore) (2016)

Impact of Ruxolitinib on Myelofibrosis Patients Post Allogeneic Stem Cell Transplant---A Pilot Study

per Pu, Jeffrey J., Poulose, Joyson, Malysz, Jozef, Zhu, Junjia, Fanburg-Smith, Julie C., Claxton, David F., Bayerl, Michael G.
Publicat a Br J Haematol (2019)

Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability

per Salzberg, Anna C., Harris-Becker, Abigail, Popova, Evgenya Y., Keasey, Nikki, Loughran, Thomas P., Claxton, David F., Grigoryev, Sergei A.
Publicat a PLoS One (2017)

Phase I study of obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia

per O'Brien, Susan M., Claxton, David F., Crump, Michael, Faderl, Stefan, Kipps, Thomas, Keating, Michael J., Viallet, Jean, Cheson, Bruce D.
Publicat a Blood (2009)

Downregulation of CD73 associates with T cell exhaustion in AML patients

per Kong, Yaxian, Jia, Bei, Zhao, Chenchen, Claxton, David F., Sharma, Arati, Annageldiyev, Charyguly, Fotos, Joseph S., Zeng, Hui, Paulson, Robert F., Prabhu, K. Sandeep, Zheng, Hong
Publicat a J Hematol Oncol (2019)

Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia – Impact on enzyme activity and response to cytotoxics

per Morad, Samy A. F., Tan, Su-Fern, Feith, David J., Kester, Mark, Claxton, David F., Loughran, Thomas P., Barth, Brian M., Fox, Todd E., Cabot, Myles C.
Publicat a Biochim Biophys Acta (2015)

Combinatorial Efficacy of Quercitin and Nanoliposomal Ceramide for Acute Myeloid Leukemia

per McGill, Colin M., Brown, Timothy J., Fisher, Lindsey N., Gustafson, Sally J., Dunlap, Kriya L., Beck, Adam J., Toran, Paul T., Claxton, David F., Barth, Brian M.
Publicat a Int J Biopharm Sci (2018)

Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients

per Jia, Bei, Wang, Liru, Claxton, David F., Ehmann, W Christopher, Rybka, Witold B., Mineishi, Shin, Rizvi, Syed, Shike, Hiroko, Bayerl, Michael, Schell, Todd D., Hohl, Raymond J., Zheng, Hong
Publicat a Blood Cancer J (2018)

VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML

per Wang, Liru, Jia, Bei, Claxton, David F., Ehmann, W Christopher, Rybka, Witold B., Mineishi, Shin, Naik, Seema, Khawaja, Muhammad R., Sivik, Jeff, Han, Junyan, Hohl, Raymond J., Zheng, Hong
Publicat a Oncoimmunology (2018)

Pentostatin, Cyclophosphamide and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group...

per Kempin, Sanford, Sun, Zhuoxin, Kay, Neil E., Paietta, Elisabeth M., Mazza, Joseph J., Ketterling, Rhett P., Frankfurt, Olga, Claxton, David F., Saltzman, Joel N., Srkalovic, Gordan, Callander, Natalie S., Gross, Gerald, Tallman, Martin S
Publicat a Acta Haematol (2019)

Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia

per Zhu, Liuluan, Kong, Yaxian, Zhang, Jianhong, Claxton, David F., Ehmann, W. Christopher, Rybka, Witold B., Palmisiano, Neil D., Wang, Ming, Jia, Bei, Bayerl, Michael, Schell, Todd D., Hohl, Raymond J., Zeng, Hui, Zheng, Hong
Publicat a J Hematol Oncol (2017)

Therapeutic Effect of Blueberry Extracts for Acute Myeloid Leukemia

per McGill, Colin M., Brown, Timothy J., Cheng, Yuan-Yin, Fisher, Lindsey N., Shanmugavelandy, Sriram S., Gustafson, Sally J., Dunlap, Kriya L., Lila, Mary Ann, Kester, Mark, Toran, Paul T., Claxton, David F., Barth, Brian M.
Publicat a Int J Biopharm Sci (2018)

Multi‐dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML

per Zhao, Chenchen, Jia, Bei, Wang, Ming, Schell, Todd D., Claxton, David F., Ehmann, W Christopher, Rybka, Witold B., Mineishi, Shin, Naik, Seema, Songdej, Natthapol, Sivik, Jeff M., Hohl, Raymond J., Zeng, Hui, Zheng, Hong
Publicat a Br J Haematol (2019)

Therapeutic Effect of Northern Labrador Tea Extracts for Acute Myeloid Leukemia

per McGill, Colin M., Tomco, Patrick L., Ondrasik, Regina M., Belknap, Kaitlyn C., Dwyer, Gaelen K., Quinlan, Daniel J., Kircher, Thomas A., Andam, Cheryl P., Brown, Timothy J., Claxton, David F., Barth, Brian M.
Publicat a Phytother Res (2018)